Holen Sie sich die Stockscreener-App
0.44
104.65%
0.225
Vorhandelsmarkt:
.38
-0.06
-13.64%
Schlusskurs vom Vortag:
$0.215
Offen:
$0.5423
24-Stunden-Volumen:
371.91M
Relative Volume:
19.76
Marktkapitalisierung:
$18.39M
Einnahmen:
$20.27M
Nettoeinkommen (Verlust:
$-63.80M
KGV:
-0.2895
EPS:
-1.52
Netto-Cashflow:
$-68.35M
1W Leistung:
+84.87%
1M Leistung:
+41.25%
6M Leistung:
+9.73%
1J Leistung:
-58.88%
1-Tages-Spanne:
$0.3941
$0.556
1-Wochen-Bereich:
$0.2106
$0.556
52-Wochen-Spanne:
$0.1417
$1.27
Carisma Therapeutics Inc Stock (CARM) Company Profile
Firmenname
Carisma Therapeutics Inc
Sektor
Branche
Telefon
(267) 491-6422
Adresse
3675 MARKET STREET, PHILADELPHIA
Vergleichen Sie CARM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CARM
Carisma Therapeutics Inc
|
0.44 | 8.98M | 20.27M | -63.80M | -68.35M | -1.52 |
|
VRTX
Vertex Pharmaceuticals Inc
|
401.00 | 100.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
577.90 | 61.55B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
447.00 | 58.53B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
706.41 | 43.59B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
332.04 | 33.67B | 3.81B | -644.79M | -669.77M | -6.24 |
Carisma Therapeutics Inc Stock (CARM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-12 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-12-10 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-04-11 | Eingeleitet | BTIG Research | Buy |
| 2023-10-03 | Eingeleitet | CapitalOne | Overweight |
| 2023-07-06 | Eingeleitet | Evercore ISI | Outperform |
| 2023-05-31 | Hochstufung | Jefferies | Hold → Buy |
| 2023-05-24 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-04-14 | Eingeleitet | Robert W. Baird | Outperform |
Alle ansehen
Carisma Therapeutics Inc Aktie (CARM) Neueste Nachrichten
Is Carisma Therapeutics Inc. building a consolidation baseMarket Trend Review & Fast Exit Strategy with Risk Control - Newser
Carisma Therapeutics Inc. stock momentum explainedQuarterly Earnings Report & Risk Managed Investment Entry Signals - Newser
How to integrate Carisma Therapeutics Inc. into portfolio analysis tools2025 Analyst Calls & Daily Technical Forecast Reports - Newser
Will Carisma Therapeutics Inc. rebound enough to break evenJuly 2025 Update & AI Driven Stock Reports - Newser
CARISMA Therapeutics Plunges 10.68% as HealthCap VII Sells Shares - AInvest
What Fibonacci levels say about Carisma Therapeutics Inc. reboundPortfolio Update Summary & Low Risk High Reward Trade Ideas - Newser
Relative strength of Carisma Therapeutics Inc. in sector analysisQuarterly Trade Report & Technical Entry and Exit Tips - Newser
Will Carisma Therapeutics Inc. price bounce be sustainableEarnings Summary Report & AI Forecast Swing Trade Picks - Newser
Carisma Therapeutics Inc. stock prediction for this week2025 Performance Recap & Weekly High Momentum Picks - Newser
Will Carisma Therapeutics Inc. see short term momentumJuly 2025 Recap & Technical Buy Zone Confirmations - Newser
Carisma Therapeutics stock soars after merger agreement with Ocugen - Investing.com
Carisma Therapeutics (CARM) Surges 118% on Merger Spark – What’s Next for This Biotech Cinderella? - AInvest
Nasdaq Down 1%; Signet Jewelers Earnings Top Views - Benzinga
Why Is Carisma Therapeutics Stock (CARM) Up 165% Today? - TipRanks
Will Carisma Therapeutics Inc. continue its uptrendMarket Growth Summary & Consistent Profit Focused Trading Strategies - Newser
Forecasting Carisma Therapeutics Inc. price range with options dataStop Loss & Daily Stock Trend Reports - Newser
Why Carisma Therapeutics Shares Are Trading Higher By 133%; Here Are 20 Stocks Moving Premarket - inkl
CARISMA Therapeutics Stock Soars 150.23% on Investor Optimism - AInvest
Published on: 2025-09-02 02:17:39 - Newser
Carisma Therapeutics Inc. stock retracement – recovery analysis2025 Winners & Losers & Fast Exit and Entry Strategy Plans - Newser
Analyzing net buyer seller activity in Carisma Therapeutics Inc.Trade Volume Summary & Weekly Stock Breakout Alerts - Newser
Does Carisma Therapeutics Inc. qualify in momentum factor screeningEarnings Recap Summary & Precise Trade Entry Recommendations - Newser
Will Carisma Therapeutics Inc. stock recover after recent dropTrade Analysis Report & Low Drawdown Trading Strategies - Newser
Applying sector rotation models to Carisma Therapeutics Inc.July 2025 Rallies & Daily Chart Pattern Signals - Newser
Visual analytics tools that track Carisma Therapeutics Inc. performanceRisk Management & Advanced Technical Signal Analysis - Newser
Tick level data insight on Carisma Therapeutics Inc. volatilityMarket Risk Report & Fast Gain Stock Trading Tips - Newser
What the charts say about Carisma Therapeutics Inc. todayTrade Volume Report & Low Risk High Reward Ideas - Newser
Combining price and volume data for Carisma Therapeutics Inc.July 2025 Patterns & Capital Efficiency Focused Ideas - Newser
Halozyme Therapeutics Inc. stock volume spike explainedTrade Risk Assessment & Fast Gain Stock Tips - Newser
Applying Wyckoff theory to Carisma Therapeutics Inc. stockEarnings Risk Summary & Smart Investment Allocation Insights - Newser
What to expect from Carisma Therapeutics Inc. in the next 30 daysJuly 2025 Decliners & Free Daily Entry Point Trade Alerts - Newser
Building trade automation scripts for Carisma Therapeutics Inc.2025 Historical Comparison & Reliable Volume Spike Alerts - Newser
Carisma Therapeutics Inc. Bounces Off Moving Average Support getLinesFromResByArray error: size == 0 - thegnnews.com
Finanzdaten der Carisma Therapeutics Inc-Aktie (CARM)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):